Abstract
BackgroundConflicting results concerning the role of soluble apoptosis molecules in rheumatic diseases still remains. In adulthood, sFas, sFasL, sBcl-2 and sTRAIL levels in lupus patients have been described as normal,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have